Pfizer
PFE
2,874 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,183 increasing their positions, 1,240 reducing their positions, and 172 closing their positions.
23% more first-time investments, than exits
New positions opened: 212 | Existing positions closed: 172
6% more funds holding in top 10
Funds holding in top 10: 31 → 33 (+2)
0% less funds holding
Funds holding: 2,875 → 2,874 (-1)
0% less capital invested
Capital invested by funds: $105B → $105B (-$332M)
5% less repeat investments, than reductions
Existing positions increased: 1,183 | Existing positions reduced: 1,240
1.16% less ownership
Funds ownership: 67.24% → 66.08% (-1.2%)
40% less call options, than puts
Call options by funds: $2.36B | Put options by funds: $3.9B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$346M |
| 2 |
Millennium Management
New York
|
+$334M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$233M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$217M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$199M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$675M |
| 2 |
D.E. Shaw & Co
New York
|
-$437M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$313M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$222M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$220M |
PFE Hedge Fund Activity: Q2 2024 in Review
2,874 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2024, worth a combined $105B — down 0.32% from $105B a quarter earlier.
Buyers outnumbered sellers: 212 funds opened new PFE positions and 172 closed out — a net gain of 40 holders — while 1,183 added to existing stakes and 1,240 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $346M. The largest seller was Capital World Investors, cutting an estimated $675M.
- 2,874 institutional investors held Pfizer (PFE) as of Q2 2024, down from 2,875 in Q1 2024.
- Funds reported $105B of Pfizer stock for Q2 2024, down 0.32% quarter-over-quarter.
- 212 funds opened new Pfizer positions in Q2 2024 and 172 closed out, a net change of +40 holders.
- The largest Pfizer buyer in Q2 2024 was Goldman Sachs, an estimated $346M added.
- The largest Pfizer seller in Q2 2024 was Capital World Investors, an estimated $675M sold.
Based on aggregated 13F filings for Q2 2024.